venetoclax
abbvie,roche
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venetoclax']
then we come to aml, perhaps the hardest of all leukaemias to treat. - "7+3 is the standard of care, but it's not a very good standard of care"
- actual results of 7+3 are worse than those in trials
- "venetoclax should be the backbone for 100% of patients with aml #asco23 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem